TABLE OF CONTENTS
|  |  |  | Volume 15, Issue 2 (June 2012) |  | In this issue
Reviews
Original Articles
Corrigenda
Also new
   AOP
| |  |  |  | Advertisement |  | |  | | Reviews | Top |  | New role for an established drug? Bisphosphonates as potential anticancer agentsH K Koul, S Koul and R B Meacham Prostate Cancer Prostatic Dis 2012 15: 111-119; advance online publication, August 30, 2011; 10.1038/pcan.2011.41 Abstract | Full Text |  |  |  | Psychological aspects of prostate cancer: a clinical reviewA De Sousa, S Sonavane and J Mehta Prostate Cancer Prostatic Dis 2012 15: 120-127; advance online publication, January 3, 2012; 10.1038/pcan.2011.66 Abstract | Full Text |  | Original Articles | Top |  | Neighborhood deprivation and prostate cancer mortality: a multilevel analysis from SwedenX Li, K Sundquist and J Sundquist Prostate Cancer Prostatic Dis 2012 15: 128-134; advance online publication, October 11, 2011; 10.1038/pcan.2011.46 Abstract | Full Text |  |  |  | Obesity-related systemic factors promote an invasive phenotype in prostate cancer cellsR S Price, D A Cavazos, R E De Angel, S D Hursting and L A deGraffenried Prostate Cancer Prostatic Dis 2012 15: 135-143; advance online publication, February 14, 2012; 10.1038/pcan.2011.54 Abstract | Full Text |  |  |  | Predictive value in the analysis of RNASEL genotypes in relation to prostate cancerM J Alvarez-Cubero, C Entrala, F Fernandez-Rosado, L J Martinez-Gonzalez, J C Alvarez, A Suarez, J A Lorente and J M Cozar Prostate Cancer Prostatic Dis 2012 15: 144-149; advance online publication, November 15, 2011; 10.1038/pcan.2011.56 Abstract | Full Text |  |  |  | Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progressionC A DeRosa, B Furusato, S Shaheduzzaman, V Srikantan, Z Wang, Y Chen, M Siefert, L Ravindranath, D Young, M Nau, A Dobi, T Werner, D G McLeod, M T Vahey, I A Sesterhenn, S Srivastava and G Petrovics Prostate Cancer Prostatic Dis 2012 15: 150-156; advance online publication, November 29, 2011; 10.1038/pcan.2011.61 Abstract | Full Text |  |  |  | Regulation of soluble VEGFR-2 secreted by microvascular endothelial cells derived from human BPHA Aweimer, T Stachon, A Tannapfel, M Köller, M C Truss and A Stachon Prostate Cancer Prostatic Dis 2012 15: 157-164; advance online publication, December 20, 2011; 10.1038/pcan.2011.63 Abstract | Full Text |  |  |  | ERG protein expression and genomic rearrangement status in primary and metastatic prostate cancer—a comparative study of two monoclonal antibodiesM Braun, D Goltz, Z Shaikhibrahim, W Vogel, D Böhm, V Scheble, K Sotlar, F Fend, S-H Tan, A Dobi, G Kristiansen, N Wernert and S Perner Prostate Cancer Prostatic Dis 2012 15: 165-169; advance online publication, January 10, 2012; 10.1038/pcan.2011.67 Abstract | Full Text |  |  |  | Prevalence of BPH and lower urinary tract symptoms in West AfricansA P Chokkalingam, E D Yeboah, A DeMarzo, G Netto, K Yu, R B Biritwum, Y Tettey, A Adjei, S Jadallah, Y Li, L W Chu, D Chia, S Niwa, A Partin, I M Thompson, C Roehrborn, R N Hoover and A W Hsing Prostate Cancer Prostatic Dis 2012 15: 170-176; advance online publication, September 13, 2011; 10.1038/pcan.2011.43 Abstract | Full Text |  |  |  | Active surveillance for low-risk prostate cancer: knowledge, acceptance and practice among urologistsM A Gorin, A Eldefrawy, O Ekwenna and M S Soloway Prostate Cancer Prostatic Dis 2012 15: 177-181; advance online publication, December 6, 2011; 10.1038/pcan.2011.57 Abstract | Full Text |  |  |  | Spurious elevation of serum PSA after curative treatment for prostate cancer: clinical consequences and the role of heterophilic antibodiesC B Anderson, A L Pyle, A Woodworth, M S Cookson, J A Smith, Jr and D A Barocas Prostate Cancer Prostatic Dis 2012 15: 182-188; advance online publication, November 22, 2011; 10.1038/pcan.2011.58 Abstract | Full Text |  |  |  | PSA screening: determinants of primary-care physician practice patternsG E Tasian, M R Cooperberg, M B Potter, J E Cowan, K L Greene, P R Carroll and J M Chan Prostate Cancer Prostatic Dis 2012 15: 189-194; advance online publication, November 29, 2011; 10.1038/pcan.2011.59 Abstract | Full Text |  |  |  | Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome StudyK Shafique, M J Proctor, D C McMillan, K Qureshi, H Leung and D S Morrison Prostate Cancer Prostatic Dis 2012 15: 195-201; advance online publication, November 29, 2011; 10.1038/pcan.2011.60 Abstract | Full Text |  |  |  | Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy schemeM Nomura, K Ito, M Miyakubo, Y Sekine, Y Tamura, N Shimizu, S Aoki and K Suzuki Prostate Cancer Prostatic Dis 2012 15: 202-209; advance online publication, December 6, 2011; 10.1038/pcan.2011.62 Abstract | Full Text |  | Corrigenda | Top |  | Elevated osteonectin/SPARC expression in primary prostate cancer predicts metastatic progressionC A DeRosa, B Furusato, S Shaheduzzaman, V Srikantan, Z Wang, Y Chen, M Siefert, L Ravindranath, D Young, M Nau, A Dobi, T Werner, D G McLeod, M T Vahey, I A Sesterhenn, S Srivastava and G Petrovics Prostate Cancer Prostatic Dis 2012 15: 210; advance online publication, December 20, 2011; 10.1038/pcan.2011.68 Full Text |  |  |  | PSA screening: determinants of primary-care physician practice patternsG E Tasian, M R Cooperberg, M B Potter, J E Cowan, K L Greene, P R Carroll and J M Chan Prostate Cancer Prostatic Dis 2012 15: 211; 10.1038/pcan.2012.8 Full Text |  |  |  | The prevalence of lower urinary tract symptoms and treatment-seeking behaviour in males over 40 years in Singapore: a community-based studyC Chong, L Fong, R Lai, W K O Lau, M Hartmann and S E Chia Prostate Cancer Prostatic Dis 2012 15: 212; advance online publication, March 20, 2012; 10.1038/pcan.2012.11 Full Text |  |  |  |  |  | Advertisement |  | 
The Arab world has a rich history of scientific breakthroughs. Ensure you're part of the scientific and medical community gaining access to breaking news in the region.
Access Nature Middle East - your free portal for scientific and medical research, features, jobs and events in the Arabic speaking world.
www.nature.com/nmiddleeast/
Follow us: Facebook, Twitter, & Google + |
|
|  | |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  |
|  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Prostate Cancer and Prostatic Diseases. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | |
|
No comments:
Post a Comment